← Leaderboards
Albert H. Owens
Fasgen, Inc.
$6,181,400
Attributed
$6,181,400
Total exposure
5
Grants
3
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $1.9M · FY2005–07$2M$1.5M$1M$500K$0
'05
'06
'07
Funding mix
By agency
NIH$6,181,400 · 5
By mechanism
R44$4,823,162 · 2
R43$1,358,238 · 3
Top collaborators
No co-investigators on record.
Others in their field
Top investigators on “Laboratory Mouse”
- Richard K. Wilson · Washington University$122,948,010
- Frank Patrick McCormick · University Of California San Francisco$87,382,096
- David Heimbrook · Leidos Biomedical Research, Inc.$81,904,667
- Kc Kent Lloyd · University Of California At Davis$56,148,943
- Alfred G Gilman · University Of Texas Sw Med Ctr/Dallas$53,869,943
- Carol J Bult · Jackson Laboratory$47,860,052
Research focus
Laboratory MouseDrug Design /Synthesis /ProductionDrug Screening /EvaluationFatty Acid SynthaseEnzyme InhibitorsClinical Trial Phase IClinical Trial Phase IiDietPharmacokineticsDosageCell LineCytotoxicityClinical ResearchObesityDoseAppetiteAntitubercular AgentsAntineoplasticsAnalytical MethodDrug KineticsBody Weight DecreasedDesignClinical TrialsCarnitine Palmitoyltransferase 1
Grant awards (14)
Fatty Acid Synthase Inhibitors: Ovarian Cancer Therapy$545,559
R44 · FY2007 · CA · contact PI
Novel Small Molecule Therapeutics to Treat Obesity$541,950
R44 · FY2007 · DK · contact PI
Fatty Acid Synthase Inhibitors: Ovarian Cancer Therapy$647,307
R44 · FY2006 · CA · contact PI
Novel Small Molecule Therapeutics to Treat Obesity$559,756
R44 · FY2006 · DK · contact PI
Treatment of Latent TB and MDR-TB with FAS20013$147,456
R43 · FY2006 · AI · contact PI
Novel Small Molecule Therapeutics to Treat Obesity$980,497
R44 · FY2005 · DK
Fatty Acid Synthase Inhibitors: Ovarian Cancer Therapy$648,424
R44 · FY2005 · CA
Treatment of Latent TB and MDR-TB with FAS20013$300,413
R43 · FY2005 · AI
Fatty Acid Synthase Inhibitors: Ovarian Cancer Therapy$649,809
R44 · FY2004 · CA
Novel Small Molecule Therapeutics to Treat Obesity$124,990
R43 · FY2004 · DK
Novel Compounds for Improved Treatment of Tuberculosis$257,441
R43 · FY2003 · AI
Fatty Acid Synthase Inhibitors: Ovarian Cancer Therapy$249,860
R44 · FY2003 · CA
Novel Small Molecule Therapeutics to Treat Obesity$249,684
R43 · FY2003 · DK
Novel Compounds for Improved Treatment of Tuberculosis$278,254
R43 · FY2002 · AI